Ophthalmia neonatorum is a severe form of conjunctivitis that affects infants within the first twenty-eight days of life. It typically stems from the transmission of infectious organisms during passage through an infected birth canal. In clinical practice across Nigeria, the two most common causative agents are Neisseria gonorrhoeae and Chlamydia trachomatis. Gonococcal infections present rapidly, usually within the first two to five days after birth, and feature copious, thick purulent discharge with marked eyelid swelling. Chlamydial infections manifest slightly later, typically between days five and fourteen, often showing milder discharge and conjunctival congestion. If left untreated, these infections can rapidly cause corneal ulceration, scarring, and permanent visual impairment or total blindness in the newborn.
Prophylaxis refers to preventative medical treatment administered to ward off a specific disease before it develops. Tetracycline hydrochloride (1%) eye ointment is widely used in Nigerian maternity units as a prophylactic agent against ophthalmia neonatorum. It acts as a broad-spectrum bacteriostatic agent, inhibiting protein synthesis in susceptible bacterial pathogens like Neisseria gonorrhoeae. Routine application forms a vital barrier that drastically reduces the incidence of neonatal eye infections, aligning with public health goals to preserve infant vision. While silver nitrate was historically used, tetracycline is preferred because it causes significantly less chemical irritation while remaining highly effective.
Administering eye ointment requires precision to ensure effectiveness and avoid injury to delicate ocular structures. Midwives must perform this procedure within the first hour after birth, after initial stabilization and resuscitation are complete.
While tetracycline ointment is generally safe, parents should be informed about normal, temporary reactions to prevent unnecessary panic. Transient chemical conjunctivitis is the most frequent observation, characterized by mild redness, slight swelling, and temporary blurring of vision. These symptoms usually resolve spontaneously within twenty-four to forty-eight hours without requiring additional intervention. Midwives must distinguish these expected, short-lived effects from true allergic reactions or worsening bacterial infections that feature persistent discharge, increasing purulence, or fever.
Professional accountability requires precise documentation and adherence to ethical standards during medication administration. The midwife must record the exact time, date, drug name, strength, and batch number in the neonate's health record. Furthermore, midwives must verify maternal consent or explain the preventative benefit clearly to parents who may be hesitant. Any adverse reactions or unusual ocular findings must be documented thoroughly and reported to the attending physician for prompt evaluation.